These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 16247516)

  • 41. Cellular localization of PACAP and its receptors in the ovary of the spotted ray Torpedo marmorata Risso 1880 (Elasmobranchii: Torpediniformes).
    Agnese M; Valiante S; Laforgia V; Andreuccetti P; Prisco M
    J Exp Zool A Ecol Genet Physiol; 2013 Jan; 319(1):1-9. PubMed ID: 23027597
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-acting analogue of vasoactive intestinal peptide, [R15, 20, 21, L17]-VIP-GRR (IK312532), protects rat alveolar L2 cells from the cytotoxicity of cigarette smoke.
    Onoue S; Endo K; Ohmori Y; Yamada S; Kimura R; Yajima T; Kashimoto K
    Regul Pept; 2004 Dec; 123(1-3):193-9. PubMed ID: 15518912
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PACAP/VIP and receptor characterization in micturition pathways in mice with overexpression of NGF in urothelium.
    Girard BM; Malley SE; Braas KM; May V; Vizzard MA
    J Mol Neurosci; 2010 Nov; 42(3):378-89. PubMed ID: 20449688
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence for the involvement of VPAC1 and VPAC2 receptors in pressure-induced vasodilatation in rodents.
    Fizanne L; Sigaudo-Roussel D; Saumet JL; Fromy B
    J Physiol; 2004 Jan; 554(Pt 2):519-28. PubMed ID: 14578481
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A structure-function study of PACAP using conformationally restricted analogs: Identification of PAC1 receptor-selective PACAP agonists.
    Ramos-Álvarez I; Mantey SA; Nakamura T; Nuche-Berenguer B; Moreno P; Moody TW; Maderdrut JL; Coy DH; Jensen RT
    Peptides; 2015 Apr; 66():26-42. PubMed ID: 25698233
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pituitary adenylate cyclase-activating polypeptide directly modulates the activity of proopiomelanocortin neurons in the rat arcuate nucleus.
    Mounien L; Bizet P; Boutelet I; Gourcerol G; Fournier A; Vaudry H; Jégou S
    Neuroscience; 2006 Nov; 143(1):155-63. PubMed ID: 16962718
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug Repositioning For Allosteric Modulation of VIP and PACAP Receptors.
    Langer I; Latek D
    Front Endocrinol (Lausanne); 2021; 12():711906. PubMed ID: 34867774
    [TBL] [Abstract][Full Text] [Related]  

  • 48. VIP and PACAP effects on mouse major pelvic ganglia neurons.
    Tompkins JD; Girard BM; Vizzard MA; Parsons RL
    J Mol Neurosci; 2010 Nov; 42(3):390-6. PubMed ID: 20428965
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stimulatory effect of pituitary adenylate cyclase-activating polypeptide 6-38, M65 and vasoactive intestinal polypeptide 6-28 on trigeminal sensory neurons.
    Sághy É; Payrits M; Helyes Z; Reglődi D; Bánki E; Tóth G; Couvineau A; Szőke É
    Neuroscience; 2015 Nov; 308():144-56. PubMed ID: 26321242
    [TBL] [Abstract][Full Text] [Related]  

  • 50. VIP enhances synaptic transmission to hippocampal CA1 pyramidal cells through activation of both VPAC1 and VPAC2 receptors.
    Cunha-Reis D; Ribeiro JA; Sebastião AM
    Brain Res; 2005 Jul; 1049(1):52-60. PubMed ID: 15935995
    [TBL] [Abstract][Full Text] [Related]  

  • 51. VIP and PACAP analogs regulate therapeutic targets in high-risk neuroblastoma cells.
    de Boisvilliers M; Perrin F; Hebache S; Balandre AC; Bensalma S; Garnier A; Vaudry D; Fournier A; Festy F; Muller JM; Chadéneau C
    Peptides; 2016 Apr; 78():30-41. PubMed ID: 26826611
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of VPAC1 receptors by VIP and PACAP-27 in human bronchial epithelial cells induces CFTR-dependent chloride secretion.
    Dérand R; Montoni A; Bulteau-Pignoux L; Janet T; Moreau B; Muller JM; Becq F
    Br J Pharmacol; 2004 Feb; 141(4):698-708. PubMed ID: 14744818
    [TBL] [Abstract][Full Text] [Related]  

  • 53. VIP-PACAP system in immunity: new insights for multitarget therapy.
    Gomariz RP; Juarranz Y; Abad C; Arranz A; Leceta J; Martinez C
    Ann N Y Acad Sci; 2006 Jul; 1070():51-74. PubMed ID: 16888149
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [TBL] [Abstract][Full Text] [Related]  

  • 55. VPAC and PAC receptors: From ligands to function.
    Dickson L; Finlayson K
    Pharmacol Ther; 2009 Mar; 121(3):294-316. PubMed ID: 19109992
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PAC1- and VPAC2 receptors in light regulated behavior and physiology: Studies in single and double mutant mice.
    Hannibal J; Georg B; Fahrenkrug J
    PLoS One; 2017; 12(11):e0188166. PubMed ID: 29155851
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors are present and biochemically active in the central nervous system of the pond snail Lymnaea stagnalis.
    Pirger Z; Laszlo Z; Hiripi L; Hernadi L; Toth G; Lubics A; Reglodi D; Kemenes G; Mark L
    J Mol Neurosci; 2010 Nov; 42(3):464-71. PubMed ID: 20396976
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of PACAP and VIP on hyperglycemia-induced proliferation in murine microvascular endothelial cells.
    Castorina A; Giunta S; Mazzone V; Cardile V; D'Agata V
    Peptides; 2010 Dec; 31(12):2276-83. PubMed ID: 20800633
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Localization and characterization of pituitary adenylate cyclase-activating polypeptide receptors in the human cerebellum during development.
    Basille M; Cartier D; Vaudry D; Lihrmann I; Fournier A; Freger P; Gallo-Payet N; Vaudry H; Gonzalez B
    J Comp Neurol; 2006 Jun; 496(4):468-78. PubMed ID: 16572459
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PACAP and VIP increase the expression of myelin-related proteins in rat schwannoma cells: involvement of PAC1/VPAC2 receptor-mediated activation of PI3K/Akt signaling pathways.
    Castorina A; Scuderi S; D'Amico AG; Drago F; D'Agata V
    Exp Cell Res; 2014 Mar; 322(1):108-21. PubMed ID: 24246222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.